Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors

Details for Australian Patent Application No. 2007275696 (hide)

Owner Amgen Inc.

Inventors Tadesse, Seifu; Tasker, Andrew; Hong, Fang-Tsao; Sham, Kelvin K. C.

Agent Shelston IP

Pub. Number AU-B-2007275696

PCT Pub. Number WO2008/011032

Priority 60/831,896 17.07.06 US

Filing date 16 July 2007

Wipo publication date 24 January 2008

Acceptance publication date 10 November 2011

International Classifications

C07D 239/82 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

22 January 2009 PCT application entered the National Phase

  PCT publication WO2008/011032 Priority application(s): WO2008/011032

10 November 2011 Application Accepted

  Published as AU-B-2007275696

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007275708-Method and system for receivables management

2007275695-High protein soybean meal